GENE ONLINE|News &
Opinion
Blog

2020-06-10| PartnerAsia-Pacific

Nobel Laureate Dr. Honjo to Speak at BIO Asia–Taiwan 2020

by GeneOnline
Share To
 
 

Dr. Tasuku Honjo (本庶 佑), Distinguished Professor of Kyoto University, Japan, shared the 2018 Nobel Prize in Medicine or Physiology for his contributions to the immune checkpoint blockade approach in cancer immunotherapy. His discoveries have been responsible in saving thousands of lives.

We are honored to announce that Dr. Tasuku Honjo will join us at BIO Asia–Taiwan 2020 as a Plenary Speaker, with his presentation titled Future of
Cancer Immunotherapy
.

 
The Early Bird special ends this week! Don’t miss your chance to join thousands of bioindustry professionals from Asia and around the world at BIO Asia–Taiwan 2020 Online + Live!
BIO Asia-Taiwan 2020 Secretariat

register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-3883

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top